Table 10.6i

Immunosuppression Use for Antirejection Treatment from Transplant

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		70	73	82	113	107	116	152	178	175	198
Tx with Antirejection Treatments		24	34	45	41	48	66	59	58	61	57
Antibodies	Any in Category	20.8%	47.1%	48.9%	36.6%	31.3%	37.9%	45.8%	39.7%	63.9%	64.9%
	Atgam/NRATG/NRATS	4.2%	0.0%	0.0%	2.4%	2.1%	0.0%	3.4%	3.4%	1.6%	3.5%
	OKT3	12.5%	44.1%	31.1%	34.1%	27.1%	27.3%	33.9%	22.4%	41.0%	52.6%
	Thymoglobulin	0.0%	11.8%	17.8%	7.3%	6.3%	3.0%	13.6%	10.3%	14.8%	12.3%
	Zenapax	4.2%	5.9%	6.7%	0.0%	2.1%	1.5%	1.7%	3.4%	3.3%	12.3%
	Simulect	0.0%	0.0%	6.7%	0.0%	0.0%	0.0%	0.0%	0.0%	1.6%	0.0%
	Campath	0.0%	0.0%	0.0%	0.0%	8.3%	15.2%	6.8%	3.4%	8.2%	3.5%
Corticosteroids	Any in Category	91.7%	85.3%	75.6%	80.5%	95.8%	92.4%	93.2%	86.2%	82.0%	82.5%
Corticosteroids	Steroids	91.7%	85.3%	75.6%	80.5%	95.8%	92.4%	93.2%	86.2%	82.0%	82.5%
Antimetabolites	Any in Category	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	0.0%	1.7%	0.0%	0.0%
	Cytoxan	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	0.0%	1.7%	0.0%	0.0%
	Methotrexate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%